NCT06690476 2024-11-15Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell CarcinomaPeking UniversityPhase EARLY_PHASE1 Recruiting74 enrolled